Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Short term Debt (2012 - 2026)

Kamada's (KMDA) quarterly Short term Debt came in at $6.0 million in Q2 2026, down 38.77% on a YoY basis from $9.8 million in Q2 2025, and down 43.33% quarter-over-quarter from $10.6 million in Q1 2026.

Analysis

Kamada (KMDA) Short term Debt (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Short term Debt for 15 consecutive years, with $6.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Short term Debt fell 38.77% year-over-year to $6.0 million; the trailing twelve-month figure through Jun 2026 stood at $6.0 million (down 38.77% YoY), and the FY2025 full-year result was $9.9 million, down 2.53% from the prior year.
  • Short term Debt eased to $6.0 million in Q2 2026 per KMDA's latest filing, from $10.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $29.7 million in Q4 2022 and bottomed at $6.0 million in Q2 2026.
  • Historically, Short term Debt has averaged $15.7 million across 5 years, with a median of $12.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Short term Debt soared 48159.62% in 2022, then sank 55.87% in 2024.
  • Over 5 years, Short term Debt stood at $29.7 million in 2022, then slumped by 49.52% to $15.0 million in 2023, then sank by 32.11% to $10.2 million in 2024, then dropped by 2.53% to $9.9 million in 2025, then tumbled by 39.22% to $6.0 million in 2026.
  • According to Business Quant data, Short term Debt over the past three periods registered $6.0 million, $10.6 million, and $9.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.03 Mn
Mar 31, 2026 10.64 Mn
Dec 31, 2025 9.92 Mn
Sep 30, 2025 10.59 Mn
Jun 30, 2025 9.85 Mn
Mar 31, 2025 10.89 Mn
Dec 31, 2024 10.18 Mn
Sep 30, 2024 9.48 Mn
Jun 30, 2024 12.61 Mn
Mar 31, 2024 12.98 Mn
Dec 31, 2023 15.00 Mn
Sep 30, 2023 15.99 Mn
Jun 30, 2023 25.08 Mn
Mar 31, 2023 29.41 Mn
Dec 31, 2022 29.71 Mn
Sep 30, 2022 25.10 Mn
Jun 30, 2022 20.12 Mn
Mar 31, 2022 19.10 Mn
Dec 31, 2021 17.99 Mn
Sep 30, 2021 52,000.00